Positron Emission Tomography in Evaluation of Dementia
Top Cited Papers
Open Access
- 7 November 2001
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 286 (17) , 2120-2127
- https://doi.org/10.1001/jama.286.17.2120
Abstract
Dementia due to progressive neurodegenerative disease is tremendously costly to patients, their families, and society in general, and is increasing in prevalence. Alzheimer disease (AD), the most common form of dementia, is estimated to affect 4 million people in the United States alone, at a cost of approximately $70 billion1,2; when indirect costs such as the lost productivity of caregivers are considered, total annual expenditures are estimated to approach $100 billion.3,4Keywords
This publication has 7 references indexed in Scilit:
- Impairment of Neocortical Metabolism Predicts Progression in Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1999
- Current Concepts in the Pathogenesis of Alzheimer’s DiseaseThe American Journal of Medicine, 1997
- Regional cerebral glucose metabolism and postmortem pathology in Alzheimer’s diseaseActa Neuropathologica, 1996
- FDG PET and Differential Diagnosis of DementiaAlzheimer Disease & Associated Disorders, 1995
- The use of positron emission tomography in the clinical assessment of dementiaSeminars in Nuclear Medicine, 1992
- Likelihood ratios with confidence: Sample size estimation for diagnostic test studiesPublished by Elsevier ,1991
- Positron Emission Tomography in the Study of Aging and Senile DementiaNeurobiology of Aging, 1980